New insights into the immunopathogenesis of systemic lupus erythematosus

The aetiology of systemic lupus erythematosus (SLE) is multifactorial, and includes contributions from the environment, stochastic factors, and genetic susceptibility. Great gains have been made in understanding SLE through the use of genetic variant identification, mouse models, gene expression studies, and epigenetic analyses. Collectively, these studies support the concept that defective clearance of immune complexes and biological waste (such as apoptotic cells), neutrophil extracellular traps, nucleic acid sensing, lymphocyte signalling, and interferon production pathways are all central to loss of tolerance and tissue damage. Increased understanding of the pathogenesis of SLE is driving a renewed interest in targeted therapy, and researchers are now on the verge of developing targeted immunotherapy directed at treating either specific organ system involvement or specific subsets of patients with SLE. Accordingly, this Review places these insights within the context of our current understanding of the pathogenesis of SLE and highlights pathways that are ripe for therapeutic targeting.

[1]  Tomoki Ito,et al.  Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus , 2011, Science Translational Medicine.

[2]  A. Belot,et al.  Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis , 2012, Pediatric Rheumatology.

[3]  J. Wren,et al.  GG-02 Epigenetic reprogramming in NAïVE CD4+ T cells favouring T cell activation and NON-TH1 effector T cell immune response as an early event in lupus flares , 2016, Lupus Science & Medicine.

[4]  G. Tsokos,et al.  Expansion of an osteopontin‐expressing T follicular helper cell subset correlates with autoimmunity in B6.Sle1b mice and is suppressed by the H1‐isoform of the Slamf6 receptor , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  B. Richardson,et al.  Murine models of lupus induced by hypomethylated T cells. , 2004, Methods in molecular medicine.

[6]  E. Bonfá,et al.  Circulating Follicular Helper–Like T Cells in Systemic Lupus Erythematosus: Association With Disease Activity , 2015, Arthritis & rheumatology.

[7]  S. Tangye,et al.  Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. , 2010, Arthritis and rheumatism.

[8]  E. Peeva,et al.  Monoclonal antibody against macrophage colony‐stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus , 2016, Clinical and experimental immunology.

[9]  J. Harley,et al.  Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. , 2004, The Journal of rheumatology.

[10]  Quanzhen Li,et al.  A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Tschopp,et al.  Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.

[12]  Shitong Wei,et al.  Therapeutic targeting of BET protein BRD4 delays murine lupus. , 2015, International immunopharmacology.

[13]  G. Gilkeson,et al.  Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. , 2003, The Journal of clinical investigation.

[14]  K. Moore,et al.  Using microRNA as an Alternative Treatment for Hyperlipidemia and Cardiovascular Disease: Cardio-miRs in the Pipeline , 2013, Journal of cardiovascular pharmacology.

[15]  A. Yoshimura,et al.  Increased expression of TLR2 in CD4+ T cells from SLE patients enhances immune reactivity and promotes IL‐17 expression through histone modifications , 2015, European journal of immunology.

[16]  L. Rönnblom,et al.  Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes , 2015, Annals of the rheumatic diseases.

[17]  J. Raes,et al.  Commensal microbiota influence systemic autoimmune responses , 2015, The EMBO journal.

[18]  B. Johnson,et al.  Impact of dietary deviation on disease progression and gut microbiome composition in lupus‐prone SNF1 mice , 2015, Clinical and experimental immunology.

[19]  C. Lau,et al.  MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis , 2014, Immune network.

[20]  M. Matsumoto,et al.  Decreased miR-26a Expression Correlates with the Progression of Podocyte Injury in Autoimmune Glomerulonephritis , 2014, PloS one.

[21]  Yong Cui,et al.  Genetic susceptibility to SLE: recent progress from GWAS. , 2013, Journal of autoimmunity.

[22]  L. Piao,et al.  Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. , 2004, International immunology.

[23]  C. Cale,et al.  Clinical Manifestations of Disease in X-Linked Carriers of Chronic Granulomatous Disease , 2013, Journal of Clinical Immunology.

[24]  H. Lorenz,et al.  Impaired Suppressive Capacity of Activation‐Induced Regulatory B Cells in Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.

[25]  A. Davidson,et al.  IFNα Inducible Models of Murine SLE , 2013, Front. Immunol..

[26]  G. Tsokos,et al.  Human TCR-αβ+ CD4− CD8− T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype1 , 2009, The Journal of Immunology.

[27]  A. Gossum,et al.  GALLSTONES AND ACUTE PANCREATITIS , 1981, The Lancet.

[28]  G. Tsokos,et al.  Cyclic Adenosine 5′-Monophosphate Response Element Modulator Is Responsible for the Decreased Expression of c-fos and Activator Protein-1 Binding in T Cells from Patients with Systemic Lupus Erythematosus , 2004, The Journal of Immunology.

[29]  A. Korganow,et al.  Circulating TFH Subset Distribution Is Strongly Affected in Lupus Patients with an Active Disease , 2013, PloS one.

[30]  Y. Shoenfeld,et al.  The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. , 2008, Autoimmunity reviews.

[31]  M. Giger,et al.  Cell Distance Mapping Identifies Functional T Follicular Helper Cells in Inflamed Human Renal Tissue , 2014, Science Translational Medicine.

[32]  M. Yandell,et al.  Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1/2 mutations. , 2014, The Journal of allergy and clinical immunology.

[33]  T. Chan,et al.  The effect of mycophenolic acid on epigenetic modifications in lupus CD4+T cells. , 2015, Clinical immunology.

[34]  G. Wolff,et al.  Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. , 2002, The Journal of nutrition.

[35]  John H Livingston,et al.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature , 2012, Nature Genetics.

[36]  G. Tsokos,et al.  Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. , 2011, Arthritis and rheumatism.

[37]  J. Alexander,et al.  Inhibition of C5a receptor alleviates experimental CNS lupus , 2010, Journal of Neuroimmunology.

[38]  C. Sokol,et al.  MRL-lpr/lpr Mice Exhibit a Defect in Maintaining Developmental Arrest and Follicular Exclusion of Anti–double-stranded DNA B Cells , 1999, The Journal of experimental medicine.

[39]  G. Hartmann,et al.  Discriminating self from non-self in nucleic acid sensing , 2016, Nature Reviews Immunology.

[40]  Shruti Sharma,et al.  Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations. , 2015, Journal of autoimmunity.

[41]  K. Honda,et al.  Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction , 2005, Nature.

[42]  D. Isenberg,et al.  Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus. , 2013, Arthritis and rheumatism.

[43]  G. Tsokos,et al.  T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. , 1989, Journal of immunology.

[44]  M. Turner,et al.  Chronic granulomatous disease as a risk factor for autoimmune disease. , 2008, The Journal of allergy and clinical immunology.

[45]  M. Reichlin,et al.  Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. , 1997, Journal of immunology.

[46]  C. Putterman,et al.  Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway. , 2013, Journal of autoimmunity.

[47]  E. Morand,et al.  Brief Report: Interleukin‐38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus , 2015, Arthritis & rheumatology.

[48]  D. Reinberg,et al.  BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones , 2014, Nature Structural &Molecular Biology.

[49]  A. Wilber,et al.  Dnase1l3 deficiency in lupus‐prone MRL and NZB/W F1 mice , 2003, Clinical and experimental immunology.

[50]  T. Rauen,et al.  Cutting Edge: Calcium/Calmodulin-Dependent Protein Kinase Type IV Is Essential for Mesangial Cell Proliferation and Lupus Nephritis , 2011, The Journal of Immunology.

[51]  M. Goulian,et al.  Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity. , 2015, Immunity.

[52]  H. Anders,et al.  Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. , 2007, Journal of the American Society of Nephrology : JASN.

[53]  M. Petri,et al.  Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial , 2011, The Lancet.

[54]  U. Lim,et al.  Dietary and lifestyle factors of DNA methylation. , 2012, Methods in molecular biology.

[55]  Xiaofeng Liao,et al.  Dynamics of Gut Microbiota in Autoimmune Lupus , 2014, Applied and Environmental Microbiology.

[56]  S. Akira,et al.  Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. , 2011, Immunity.

[57]  C. Tsatsanis,et al.  Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. , 2006, Arthritis and rheumatism.

[58]  Zhe Zhang,et al.  Monocyte enhancers are highly altered in systemic lupus erythematosus. , 2015, Epigenomics.

[59]  G. Pruijn,et al.  Identification of novel Y RNA-binding proteins , 2000 .

[60]  C. Reilly,et al.  Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice. , 2016, Clinical immunology.

[61]  T. Horiuchi,et al.  Mutation of DNASE1 in people with systemic lupus erythematosus , 2001, Nature Genetics.

[62]  Yuanyuan Wu,et al.  IRF5 Deficiency Ameliorates Lupus but Promotes Atherosclerosis and Metabolic Dysfunction in a Mouse Model of Lupus-Associated Atherosclerosis , 2015, The Journal of Immunology.

[63]  L. Ivashkiv,et al.  TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon–response genes , 2008, Nature Immunology.

[64]  Ec Beachler Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003 .

[65]  J. Connolly,et al.  RNA sensing by conventional dendritic cells is central to the development of lupus nephritis , 2015, Proceedings of the National Academy of Sciences.

[66]  O. Otsubo,et al.  Selective deficiency of C1s associated with a systemic lupus erythematosus-like syndrome. Report of a case. , 1992, Arthritis and rheumatism.

[67]  G. Papp,et al.  A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus , 2016, Clinical and experimental immunology.

[68]  Melvyn W B Zhang,et al.  A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. , 2016, Autoimmunity reviews.

[69]  B. Weill,et al.  FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus. , 1999, European cytokine network.

[70]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[71]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Daniel R. Caffrey,et al.  AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC , 2009, Nature.

[73]  V. Werth,et al.  Pathophysiology of cutaneous lupus erythematosus , 2015, Arthritis research & therapy.

[74]  A. Stevens,et al.  Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1. , 2008, Rheumatology.

[75]  N. Knowlton,et al.  Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients , 2008, Genes and Immunity.

[76]  J. Cyster,et al.  Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. , 2004, Immunity.

[77]  J. Alexander,et al.  C5a alters blood‐brain barrier integrity in experimental lupus , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[78]  D. Ye,et al.  PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr Mice , 2012, Molecular Biology Reports.

[79]  R. Lahesmaa,et al.  Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature. , 2014, Antioxidants & redox signaling.

[80]  Ligang Wu,et al.  Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. , 2008, Molecular cell.

[81]  JC Crispín,et al.  IL-17-producing T cells in lupus nephritis , 2011, Lupus.

[82]  Y. Belkaid,et al.  Role of the Microbiota in Immunity and Inflammation , 2014, Cell.

[83]  C. Langefeld,et al.  Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies , 2009, Nature Reviews Genetics.

[84]  G. Pruijn,et al.  Analysis of the molecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNA-binding proteins. , 2000, European journal of biochemistry.

[85]  L. Hilbrands,et al.  Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice , 2015, Arthritis Research & Therapy.

[86]  M. Kretzler,et al.  Toll-like receptor-7 modulates immune complex glomerulonephritis. , 2005, Journal of the American Society of Nephrology : JASN.

[87]  H. Cathro,et al.  Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex–mediated acute lupus glomerulonephritis , 2013, The Journal of experimental medicine.

[88]  F. Arnett,et al.  Clinical presentations and molecular basis of complement C1r deficiency in a male African–American patient with systemic lupus erythematosus , 2011, Lupus.

[89]  A. Davidson,et al.  BAFF and selection of autoreactive B cells. , 2011, Trends in immunology.

[90]  J. Casanova,et al.  Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation , 2014, Nature.

[91]  L. Arnaud,et al.  Ultraviolet light converts propranolol, a nonselective β‐blocker and potential lupus‐inducing drug, into a proinflammatory AhR ligand , 2015, European journal of immunology.

[92]  F. Rieux-Laucat,et al.  Are RASopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus? Case report and systematic review of the literature. , 2013, Seminars in arthritis and rheumatism.

[93]  D. Iliopoulos,et al.  Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression , 2011, Annals of the rheumatic diseases.

[94]  Q. Lu,et al.  Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus. , 2016, Journal of autoimmunity.

[95]  J. Pers,et al.  TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity. , 2012, Journal of autoimmunity.

[96]  Jiucun Wang,et al.  T Follicular Helper Cells Mediate Expansion of Regulatory B Cells via IL-21 in Lupus-Prone MRL/lpr Mice , 2013, PloS one.

[97]  B. Eiz-Vesper,et al.  Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus. , 2008, Arthritis and rheumatism.

[98]  V. Pascual,et al.  Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors , 2008, Proceedings of the National Academy of Sciences.

[99]  Cheol‐Hee Kim,et al.  Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. , 2015, American journal of human genetics.

[100]  Zhe Zhang,et al.  Cytokine-Induced Monocyte Characteristics in SLE , 2010, Journal of biomedicine & biotechnology.

[101]  Kristy Brown,et al.  Aicardi–Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies , 2014, Annals of the rheumatic diseases.

[102]  Christophe Pellefigues,et al.  Immunoglobulin E plays an immunoregulatory role in lupus , 2014, The Journal of experimental medicine.

[103]  J. Pers,et al.  BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.

[104]  F. Q. Ribeiro The meta-analysis , 2017, Brazilian journal of otorhinolaryngology.

[105]  G. Barber,et al.  STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.

[106]  R. Rosenfeld Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[107]  C D Langefeld,et al.  Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort , 2011, Genes and Immunity.

[108]  S. Akira,et al.  Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. , 2008, Arthritis and rheumatism.

[109]  S. Pillai,et al.  B cells and autoimmunity. , 2011, Current opinion in immunology.

[110]  E. Wakeland,et al.  T/B‐cell interactions are more transient in response to weak stimuli in SLE‐prone mice , 2014, European journal of immunology.

[111]  F. Lund-Johansen,et al.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.

[112]  G. Tsokos,et al.  A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus. , 2014, Clinical immunology.

[113]  G. Hughes,et al.  Morbidity and mortality in systemic lupus erythematosus during a 5-year period - A multicenter prospective study of 1,000 patients , 1999 .

[114]  Annalisa Ballarini,et al.  Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. , 2006, American journal of human genetics.

[115]  J. Wren,et al.  Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients. , 2013, Journal of autoimmunity.

[116]  L. Tam,et al.  Cost‐of‐illness studies in systemic lupus erythematosus: A systematic review , 2011, Arthritis care & research.

[117]  Constantin Polychronakos,et al.  Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases , 2016 .

[118]  B. Beutler,et al.  Immunopathology and Infectious Diseases Viral RNA Induces Type I Interferon-Dependent Cytokine Release and Cell Death in Mesangial Cells via Melanoma-Differentiation-Associated Gene-5 Implications for Viral Infection-Associated Glomerulonephritis , 2010 .

[119]  Z. Xu,et al.  Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients , 2007, Lupus.

[120]  Y. Crow,et al.  Aicardi–Goutières syndrome and the type I interferonopathies , 2015, Nature Reviews Immunology.

[121]  K. Sullivan,et al.  Monocyte polarization: the relationship of genome-wide changes in H4 acetylation with polarization , 2011, Genes and Immunity.

[122]  V. Kuchroo,et al.  High Ro52 expression in spontaneous and UV-induced cutaneous inflammation. , 2009, The Journal of investigative dermatology.

[123]  J. Chiorini,et al.  Gene Expression Profiles from Disease Discordant Twins Suggest Shared Antiviral Pathways and Viral Exposures among Multiple Systemic Autoimmune Diseases , 2015, PloS one.

[124]  Angela M. Yu,et al.  The SLE Transcriptome Exhibits Evidence of Chronic Endotoxin Exposure and Has Widespread Dysregulation of Non-Coding and Coding RNAs , 2014, PloS one.

[125]  J. Harley,et al.  Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. , 2016, Journal of autoimmunity.

[126]  C. Putterman,et al.  BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[127]  L. Morel,et al.  Genetic Determination of T Cell Help in Loss of Tolerance to Nuclear Antigens1 , 2005, The Journal of Immunology.

[128]  S. Makni,et al.  Pediatric Systemic Lupus Erythematosus with C1q Deficiency , 2007, Annals of the New York Academy of Sciences.

[129]  P. Rémy,et al.  Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. , 2001, Kidney international.

[130]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[131]  Stefan Schoenfelder,et al.  Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci , 2015, Nature Communications.

[132]  J. Wrammert,et al.  High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination , 2015, PloS one.

[133]  Virginia Pascual,et al.  Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients , 2016, Cell.

[134]  M. Shlomchik,et al.  Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.

[135]  D. Chaplin,et al.  Deletion of C4A genes in patients with systemic lupus erythematosus. , 1987, Arthritis and rheumatism.

[136]  B. Beutler,et al.  Intracellular nucleic acid sensors and autoimmunity. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[137]  G. Tsokos,et al.  A systemic lupus erythematosus gene expression array in disease diagnosis and classification: a preliminary report , 2011, Lupus.

[138]  Xiang-Pei Li,et al.  Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis , 2012, Molecular Biology Reports.

[139]  R. Medzhitov,et al.  Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA , 2006, Nature Immunology.

[140]  M. Petri,et al.  The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis , 2015, Arthritis & rheumatology.

[141]  M. Peterson,et al.  Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus , 2004 .

[142]  G. Illei,et al.  Autoreactive IgE Is Prevalent in Systemic Lupus Erythematosus and Is Associated with Increased Disease Activity and Nephritis , 2014, PloS one.

[143]  Jing Wang,et al.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.

[144]  Bo Gao,et al.  Significance of CD163-Positive Macrophages in Proliferative Glomerulonephritis , 2015, The American journal of the medical sciences.

[145]  M. Shlomchik,et al.  NADPH Oxidase Inhibits the Pathogenesis of Systemic Lupus Erythematosus , 2012, Science Translational Medicine.

[146]  B. Pussell,et al.  COMPLEMENT DEFICIENCY AND NEPHRITIS A Report of a Family , 1980, The Lancet.

[147]  R. Talaat,et al.  Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. , 2015, Cytokine.

[148]  P. Gregersen,et al.  Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. , 2012, American journal of human genetics.

[149]  Marie Olliver Linking innate and adaptive immunity to streptococcus pneumoniae , 2012 .

[150]  S. Kagami,et al.  Sisters with α-mannosidosis and systemic lupus erythematosus , 2004, European Journal of Pediatrics.

[151]  J. Harley,et al.  Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification , 2016, Annals of the rheumatic diseases.

[152]  C. Grimaldi Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells , 2006, Current opinion in rheumatology.

[153]  Ha Won Kim,et al.  Activated STING in a vascular and pulmonary syndrome. , 2014, The New England journal of medicine.

[154]  Takahisa Suzuki,et al.  Lupus Nephritis IgG Induction of Calcium/Calmodulin‐Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function , 2015, Arthritis & rheumatology.

[155]  Marta E Alarcón-Riquelme,et al.  Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. , 2005, Arthritis and rheumatism.

[156]  Scott M. Williams,et al.  Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production , 2013, PLoS genetics.

[157]  G. Tsokos,et al.  Molecular Basis of Deficient IL-2 Production in T Cells from Patients with Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.

[158]  Mårten Segelmark,et al.  Circulating microRNA expression profiles associated with systemic lupus erythematosus. , 2013, Arthritis and rheumatism.

[159]  L. Lagae,et al.  Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 , 2015, American journal of medical genetics. Part A.

[160]  J. Harley,et al.  Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[161]  H. Ploegh,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003 .

[162]  D. Choubey Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility. , 2012, Immunology letters.

[163]  G. Hughes,et al.  Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. , 1999, Medicine.

[164]  L. Notarangelo,et al.  Impaired receptor editing and heterozygous RAG2 mutation in a patient with systemic lupus erythematosus and erosive arthritis. , 2015, The Journal of allergy and clinical immunology.

[165]  P. Heyder,et al.  Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. , 2004, Arthritis and rheumatism.

[166]  S. Akira,et al.  Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus , 2005, The Journal of experimental medicine.

[167]  G. Tsokos,et al.  T Cell Transcriptomes Describe Patient Subtypes in Systemic Lupus Erythematosus , 2015, PloS one.

[168]  N. Hacohen,et al.  TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity , 2015, Nature Immunology.

[169]  C. Reilly,et al.  HDAC expression and activity is upregulated in diseased lupus-prone mice. , 2015, International immunopharmacology.

[170]  J. Connolly,et al.  Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus , 2011, Science Translational Medicine.

[171]  M. Sherman,et al.  A Preliminary Report , 1953 .

[172]  F. Turroni,et al.  Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus , 2014, mBio.

[173]  Andreas Radbruch,et al.  Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus , 2015, Annals of the rheumatic diseases.

[174]  M. Oukka,et al.  Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1 , 2008, The Journal of Immunology.

[175]  T. Thai,et al.  Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Faslpr mouse , 2013, Proceedings of the National Academy of Sciences.

[176]  S Hanash,et al.  Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[177]  Paul A. Renauer,et al.  Renal involvement in lupus is characterized by unique DNA methylation changes in naïve CD4+ T cells. , 2015, Journal of autoimmunity.

[178]  P. Lipsky,et al.  Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus1 , 2000, The Journal of Immunology.

[179]  J. O’Shea,et al.  Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. , 2009, Immunity.

[180]  C. Mawrin,et al.  Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. , 2005, The Journal of clinical investigation.

[181]  V. Kuchroo,et al.  Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23–Th17 pathway , 2009, The Journal of experimental medicine.

[182]  M. Urowitz,et al.  Mortality in systemic lupus erythematosus. , 1987, Arthritis and rheumatism.

[183]  Jie Dong,et al.  MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. , 2013, Arthritis and rheumatism.

[184]  Melvyn W B Zhang,et al.  Genetic Variants That Are Associated with Neuropsychiatric Systemic Lupus Erythematosus , 2016, The Journal of Rheumatology.

[185]  F. Middleton,et al.  Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation1 , 2009, The Journal of Immunology.

[186]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[187]  P. Lipsky,et al.  Abnormalities of B cell subsets in patients with systemic lupus erythematosus. , 2011, Journal of immunological methods.

[188]  Paolo Raggi,et al.  Premature coronary-artery atherosclerosis in systemic lupus erythematosus. , 2003, The New England journal of medicine.

[189]  Matthias Kretzler,et al.  Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus , 2011, The Journal of Immunology.

[190]  W. Schoeppe,et al.  Elevated levels of soluble CD 14 in serum of patients with systemic lupus erythematosus , 1994, Clinical and experimental immunology.

[191]  M. Boaz,et al.  Prolactin and Autoimmunity , 2012, Clinical Reviews in Allergy & Immunology.

[192]  Michael A. Smith,et al.  Self-reactive IgE exacerbates interferon responses associated with autoimmunity , 2015, Nature Immunology.

[193]  Zhe Zhang,et al.  Global H4 acetylation analysis by ChIP-chip in SLE monocytes , 2009, Genes and Immunity.

[194]  Yuanjia Tang,et al.  MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1 , 2010, The Journal of Immunology.

[195]  H. Ueno,et al.  OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response. , 2015, Immunity.

[196]  Lingyun Sun,et al.  Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression , 2008, Lupus.

[197]  K. Elkon,et al.  Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease , 2015, Nature Medicine.

[198]  P. Nelson,et al.  Viruses as potential pathogenic agents in systemic lupus erythematosus , 2014, Lupus.

[199]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[200]  J. Atkinson,et al.  C2 deficiency and a lupus erythematosus-like illness: family re-evaluation. , 1979, Annals of internal medicine.

[201]  T. Phan,et al.  Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.

[202]  Yong Dai,et al.  Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients , 2009, Rheumatology International.

[203]  Carolyne Smith,et al.  The role of neutrophils in the pathogenesis of systemic lupus erythematosus , 2015, Current opinion in rheumatology.

[204]  M. Petri,et al.  Interferon Regulatory Factor 1 Marks Activated Genes and Can Induce Target Gene Expression in Systemic Lupus Erythematosus , 2015, Arthritis & rheumatology.

[205]  P. Schur,et al.  Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. , 1996, The Journal of clinical investigation.

[206]  X. Ding,et al.  Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. , 1998, The Journal of clinical investigation.

[207]  D. Barnes,et al.  Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. , 2007, American journal of human genetics.

[208]  K. Tenbrock,et al.  Aicardi-Goutières Syndrome and Systemic Lupus Erythematosus (SLE) in a 12-Year-Old Boy With SAMHD1 Mutations , 2011, Journal of child neurology.

[209]  G. Illei,et al.  BASOPHILS AND THE T HELPER 2 ENVIRONMENT CAN PROMOTE THE DEVELOPMENT OF LUPUS NEPHRITIS , 2010, Nature Medicine.

[210]  John E. Connolly,et al.  Systemic IFN‐α drives kidney nephritis in B6.Sle123 mice , 2008, European journal of immunology.

[211]  Bohdan Waszkowycz,et al.  Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. , 2013, Arthritis and rheumatism.

[212]  K. Skak,et al.  Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression. , 2003, Blood.

[213]  I. Hambleton,et al.  Lupus nephritis in an Afro-Caribbean population: renal indices and clinical outcomes , 2006, Lupus.

[214]  T. Yao,et al.  Impaired phagocytosis and susceptibility to infection in pediatric-onset systemic lupus erythematosus , 2013, Lupus.

[215]  J. Fransen,et al.  Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis , 2015, Arthritis & rheumatology.

[216]  Hai Qi,et al.  MicroRNAs of the miR-17~92 family are critical regulators of TFH differentiation , 2013, Nature Immunology.

[217]  Ruslan Medzhitov,et al.  Toll-like receptors: linking innate and adaptive immunity. , 2005, Advances in experimental medicine and biology.

[218]  F. Rieux-Laucat,et al.  Tartrate resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature , 2010, Nature Genetics.

[219]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[220]  P. Boor,et al.  Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. , 2006, Journal of the American Society of Nephrology : JASN.

[221]  A. Fischer,et al.  Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. , 2014, The Journal of allergy and clinical immunology.

[222]  H. Makino,et al.  Gene expression of PDGF and PDGF receptor in various forms of glomerulonephritis. , 1997, American journal of nephrology.

[223]  M. Petri,et al.  A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[224]  F. Rieux-Laucat,et al.  Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. , 1995, Science.

[225]  M. Madaio,et al.  Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner. , 2011, Arthritis and rheumatism.

[226]  G. Tsokos,et al.  Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice , 2013, BioMed research international.

[227]  K. Lauber,et al.  CRP/anti-CRP Antibodies Assembly on the Surfaces of Cell Remnants Switches Their Phagocytic Clearance Toward Inflammation , 2011, Front. Immun..

[228]  山脇 成人,et al.  ストレスによるラット脳内 Calcium/calmodulin dependent protein kinase II の発現量リン酸化およびリン酸化に関する検討 , 2002 .

[229]  H. Khalak,et al.  Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus , 2011, Nature Genetics.

[230]  L. Gesualdo,et al.  Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells , 2015, Arthritis Research & Therapy.

[231]  K. Sullivan,et al.  Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus. , 2006, Rheumatology.

[232]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[233]  Sean C. Bendall,et al.  Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus. , 2015, The Journal of allergy and clinical immunology.

[234]  E. Remmers,et al.  Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. , 2015, The Journal of clinical investigation.

[235]  M. Ehrenstein,et al.  Regulatory T‐cells in systemic lupus erythematosus and rheumatoid arthritis , 2011, FEBS letters.

[236]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[237]  M. Nambiar,et al.  Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[238]  P. Gaffney,et al.  Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. , 2014, Journal of the American Society of Nephrology : JASN.

[239]  K. Hiromura,et al.  Glomerular cytokine expression in murine lupus nephritis , 2016, Clinical and Experimental Nephrology.

[240]  Gene W. Yeo,et al.  The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression , 2015, Science.

[241]  E. Christensen,et al.  Prolidase deficiency: it looks like systemic lupus erythematosus but it is not , 2010, European Journal of Pediatrics.

[242]  A. Bengtsson,et al.  Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus , 2014, Arthritis Research & Therapy.

[243]  A. Coutinho,et al.  Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus , 2012, Clinics.

[244]  G. Gilkeson,et al.  Estrogen Receptors in Immunity and Autoimmunity , 2011, Clinical reviews in allergy & immunology.